Commutable calibrator with value assigned by the IFCC reference procedure to harmonize serum lactate dehydrogenase activity results measured by 2 different methods

Clinical Chemistry

Volumn 54, Issue 8, 2008, Pages 1349-1355

  Cattozzo, Giampaolo ^a   Guerra, Elena ^b   Ceriotti, Ferruccio ^b   Franzini, Carlo ^c  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Diagnostica e Ricerca S Raffaele spa   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; LACTATE DEHYDROGENASE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATOR; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; REFERENCE VALUE;

CALIBRATION; CHEMISTRY, CLINICAL; CLINICAL ENZYME TESTS; GUIDELINES AS TOPIC; HUMANS; L-LACTATE DEHYDROGENASE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 49149102148     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.100081     Document Type: Article

References (40)

1. Panteghini M, Bais R, van Solinge WW. Enzymes. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed. St. Louis: Elsevier, 2006;601-3.
2. Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clin Chem 2002;48:1151-9.
3. Suh SY, Ahn HY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer 2007;43:1051-9.
4. Riley RD, Heney D, Jones RD, Sutton AJ, Lambert PC, Abrams KR, et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004;10:4-12.
5. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, et al. An evidence-based staging system for cutaneous melanoma [Review]. CA Cancer J Clin 2004;54:131-49.
6. Dhaliwai G, Cornett PA, Tierney LM. Hemolytic anemia. Am Fam Physician 2004;69:2599-606.
7. Hui DS, Chan MC, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J 2004;80:373-81.
8. Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005;90:391-9.
9. Ernam D, Atalay F, Hasanoglu HC, Kaplan O. Role of biochemical tests in the diagnosis of exudative pleural effusions. Clin Biochem 2005;38:19-23.
10. Demetriou JA, Drewers PA, Gin JB. Enzymes. In: Henry RJ, Cannon DC, Winkelman JW. Clinical Chemistry: Principles and Techniques, 2nd ed. New York: Harper & Row, 1974;919-32.
11. Siekmann L, Bonora R, Burtis CA, Ceriotti F, Clerc-Renaud P, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 1. The concept of reference procedure for the measurement of catalytic activity concentrations of enzymes. Clin Chem Lab Med 2002;40:631-4.
12. Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin Chem Lab Med 2002;40:643-8.
13. Siekmann L, Bonora R, Burtis CA, Ceriotti F, Clerc-Renaud P, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 7. Certification of four reference materials for the determination of enzymatic activity of γ-glutamyltransferase, lactate dehydrogenase, alanine aminotransferase and creatine kinase according to IFCC reference procedures at 37°C. Clin Chem Lab Med 2002;40:739-45.
14. Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentration of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 2003;327:69-79.
15. Panteghini M, Ceriotti F, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2001;39:795-800.
16. Jansen R, Schumann G, Baadenhuijsen H, Franck P, Franzini C, Kruse R, et al. Trueness verification and traceability assessment of results from commercial systems for measurement of six enzyme activities in serum: an international study in the EC4 framework of Calibration 2000 project. Clin Chim Acta 2006;368:160-7.
17. QCNet. http://sde.qcnet.com/sde/reports/unityWWReports.aspx (Accessed February 2008).
18. Dybkaer R. Vocabulary for use in measurement procedures and description of reference materials in laboratory medicine. Eur J Clin Chem Clin Biochem 1997;35:141-73.
19. International Standards Organization. In vitro diagnostic medical devices: measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials. ISO/FDIS 17511, 2002.
20. Fasce CF Jr, Rej R, Copeland WH, Vanderlinde RE. A discussion of enzyme reference materials: applications and specifications. Clin Chem 1973;19:5-9.
21. Franzini C. Commutability of reference materials in clinical chemistry. J Int Fed Clin Chem 1993;5:169-73.
22. Rej R. Accurate enzyme activity measurements: two decades of development in the commutability of enzyme quality control materials. Arch Pathol Lab Med 1993;117:352-64.
23. Brion E, Lessinger JM, Gould N, Leyendecker J, Férard J. Evaluation of commutability of control materials. Clin Chem Lab Med 2002;40:625-30.
24. Franzini C, Ceriotti F. Impact of reference materials on accuracy in clinical chemistry. Clin Biochem 1998;31:449-57.
25. Miller WG. Specimen materials, target values and commutability for external quality assessment (proficiency testing) schemes. Clin Chim Acta 2003;327:25-37.
26. Cattozzo G, Franzini C, Melzi d'Eril G. Commutability of calibration and control materials for serum lipase. Clin Chem 2001;47:2108-13.
27. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods: applications of linear regression procedures for method comparison studies in clinical chemistry. J Clin Chem Clin Biochem 1983;21:709-20.
28. van Helden WC, Visser RW, Van den Bergh FA, Souverijn JH. Comparison of intermethod analytical variability of patient sera and commercial quality control sera. Clin Chim Acta 1979;93:335-47.
29. Middle JG, Libeer JC, Malakhov V, Penttila I. Characterisation and evaluation of external quality assessment scheme serum. Clin Chem Lab Med 1998;36:119-30.
30. Cattozzo G, Franzini C, Melzi d'Eril GV. Myoglobin and creatine kinase MB mass assays: intermethod variability of patient sera and commercially available control materials. Clin Chim Acta 2001;303:55-60.
31. Ledue TB, Johnson AM. Commutability of serum protein values: persisting bias among manufacturers using values assigned from the certified reference material 470 (CRM 470) in the United States. Clin Chem Lab Med 2001;39:1129-33.
32. Miller WG, Myers GL, Rej R. Why commutability matters [Editorial]. Clin Chem 2006;52:553-4.
33. Franck PF, Steen G, Lombarts AJ, Souverijn JH, van Wermeskerken RK. Multicenter harmonization of common enzyme results by fresh patient-pool sera. Clin Chem 1998;44:614-21.
34. Muller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000;46:1907-9.
35. Baadenhuijsen H, Kuypers A, Weykamp C, Cobbaert C, Jansen R. External quality assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch "Calibration 2000" project. Clin Chem Lab Med 2005;43:304-7.
36. Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Panteghini M, et al. Towards standardization of cardiac troponin I measurement. Part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. Clin Chem 2006;52:1685-92.
37. Myers GL, Eckfeldt JH, Greenberg N, Levine JB, Miller WG, Wiebe DA. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures; approved guideline. NCCLS C37-A, 1999.
38. Ricòs C, Alvarez V, Cava F, García-Lario JV, Hernàndez A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
39. Westgard QC. Clinical quality requirements: European biologic goals and calculated biologic allowable total errors. http://www.westgard.com/europe.htm (Accessed August 2007).
40. International Standards Organization. In vitro diagnostic medical devices: measurement of quantities in samples of biological origin - metrological traceability of values for catalytic concentration of enzymes assigned to calibrators and control materials. ISO/FDIS 18153, 2003.